The Intelligence from The Economist cover image

Clotting factors: the AstraZeneca vaccine

The Intelligence from The Economist

00:00

Intro

This chapter examines recent analysis by European and British regulators regarding the potential link between blood clots and the AstraZeneca-Oxford COVID vaccine. It discusses the implications of these findings, the cautious stance of health authorities, and the effects on public perception and vaccine rollout.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app